𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Predictive factors of acute hospitalization in 134 patients with Alzheimer's disease: a one year prospective study

✍ Scribed by Sandrine Andrieu; Emma Reynish; Fati Nourhashemi; Annabelle Shakespeare; Sophie Moulias; Pierre Jean Ousset; Pierre Sagnier; Alain Richard; Jean-Louis Albarede; Bruno Vellas


Publisher
John Wiley and Sons
Year
2002
Tongue
English
Weight
61 KB
Volume
17
Category
Article
ISSN
0885-6230

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Objective

To evaluate the frequency of and determine predictive factors for acute hospitalization in a prospective study of patients with Alzheimer's disease (AD).

Design

A one year prospective study.

Participants

134 patients recruited from the memory clinic in Toulouse University Hospital, with AD diagnosed using the NINCDS‐ADRDA criteria.

Measures

A comprehensive geriatric and neuropsychological assessment was conducted 6 monthly.

Results

Among the 134 patients included in this study, at one year follow up, 32 patients had at least one acute hospitalization. Patient‐related variables predictive of acute hospitalization in the univariate analysis were: level of education, ADL‐bathing, ADL‐toileting, ADL‐feeding, total ADL score, IADL A scale (daily upkeep), history of falls, and level of behavioural disorder as measured by the Cohen scale. In the multivariate regression model, two variables were associated with acute hospitalization: dependency for ADL‐bathing [Odds Ratio (OR) = 5.65, 95% Confidence Intervals (CI): 2.3–14.4] and low level of education.

Conclusion

The results of this study demonstrate that acute hospitalization is frequent in AD patients resulting in considerable cost implications. Interventions that support patients and their cares to manage their loss of ADL may be a practical approach to reducing the need for acute hospital admissions. Copyright © 2002 John Wiley & Sons, Ltd.


📜 SIMILAR VOLUMES


Factors associated with mortality in pat
✍ Akinori Ueki; Hidetaka Shinjo; Hiroko Shimode; Takaya Nakajima; Yoshio Morita 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 69 KB 👁 1 views

To identify neuropsychiatric and somatic factors related to survival in early-onset Alzheimer's disease, we longitudinally studied 108 patients (35 male, 73 female) with early-onset Alzheimer's disease who were 46 to 64 years old at onset and 50 to 69 years old when diagnosed at our institution. A f

Skill learning in patients with moderate
✍ Alexander Rösler; Erich Seifritz; Kurt Kräuchi; David Spoerl; Ilona Brokuslaus; 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 35 KB 👁 1 views

## Abstract The authors report the effect of a 12‐day prospective, blinded dance‐learning trial in 5 patients with moderate Alzheimer's disease (AD) and 5 age‐matched depressed patients. Patients with AD showed a significant effect in procedural learning whereas depressed patients did not. These fi

The effects of music therapy on reducing
✍ Maryam Zare; Azizeh Afkham Ebrahimi; Behrooz Birashk 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 64 KB 👁 2 views

A Memory Clinic model set up to diagnose and treat Alzheimer's Disease early in the course of the illness delayed time to institutionalisation by a median of 9 months compared to controls. Treatment included pre and post diagnostic counselling, and psychosocial interventions.

Influence of familial factors on radiolo
✍ Botha-Scheepers, Stella A. ;Watt, Iain ;Slagboom, Eline ;Meulenbelt, Ingrid ;Ros 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 81 KB 👁 2 views

## Abstract ## Objective The contribution of genetics to osteoarthritis (OA) progression is not known. To gain more insight into whether familial factors play a role in disease progression of OA, we analyzed familial aggregation of radiologic OA progression in a study of sibling pairs (the Genetic

Safety and tolerability of rivastigmine
✍ Jason T. Olin; Vinod Bhatnagar; Patricio Reyes; Barbara Koumaras; Xiangyi Meng; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 139 KB 👁 1 views

## Abstract ## Objective Rivastigmine, a dual cholinesterase inhibitor (ChEI), is widely approved for the symptomatic treatment of both mild‐to‐moderate Alzheimer's disease (AD) and Parkinson's disease dementia. Orally administered ChEIs may be associated with gastrointestinal (GI) side effects an